{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:17:46Z","timestamp":1779243466913,"version":"3.51.4"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T00:00:00Z","timestamp":1367884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/nrgastro.2013.69","type":"journal-article","created":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T06:47:15Z","timestamp":1367909235000},"page":"413-422","source":"Crossref","is-referenced-by-count":40,"title":["State-of-the-art medical prevention of postoperative recurrence of Crohn's disease"],"prefix":"10.1038","volume":"10","author":[{"given":"Dario","family":"Sorrentino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,7]]},"reference":[{"key":"BFnrgastro201369_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/gast.2002.31072","volume":"122","author":"WJ Sandborn","year":"2002","unstructured":"Sandborn, W. J.  et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 122, 512\u2013530 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1053\/j.gastro.2009.02.090","volume":"137","author":"D Sorrentino","year":"2009","unstructured":"Sorrentino, D. & Paviotti, A. Postsurgical recurrence of Crohn's disease: the beginning of the end? Gastroenterology 137, 1181\u20131182 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/ibd.21355","volume":"17","author":"M Regueiro","year":"2011","unstructured":"Regueiro, M.  et al. Crohn's disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection. Inflamm. Bowel Dis. 17, 118\u2013126 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1053\/j.gastro.2004.06.002","volume":"127","author":"SB Hanauer","year":"2004","unstructured":"Hanauer, S. B.  et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 127, 723\u2013729 (2004).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR5","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1001\/archinte.167.16.1804","volume":"167","author":"D Sorrentino","year":"2007","unstructured":"Sorrentino, D., Terrosu, G., Avellini, A. & Maiero, S. Infliximab and low dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn's disease. Arch. Intern. Med. 167, 1804\u20131810 (2007).","journal-title":"Arch. Intern. Med."},{"key":"BFnrgastro201369_CR6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/ibd.21524","volume":"17","author":"TD Walters","year":"2011","unstructured":"Walters, T. D.  et al. Validating Crohn's disease activity indices for use in assessing postoperative recurrence. Inflamm. Bowel Dis. 17, 1547\u20131556 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR7","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","volume":"99","author":"P Rutgeerts","year":"1990","unstructured":"Rutgeerts, P.  et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 99, 956\u2013963 (1990).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR8","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1136\/gut.2005.088658","volume":"55","author":"DB Sachar","year":"2006","unstructured":"Sachar, D. B. Recurrence rates in Crohn's disease: predicting the future and predicting the past. Gut 55, 1069\u20131070 (2006).","journal-title":"Gut"},{"key":"BFnrgastro201369_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.cgh.2007.08.020","volume":"6","author":"JP Terdiman","year":"2008","unstructured":"Terdiman, J. P. Prevention of postoperative recurrence in Crohn's disease. Clin. Gastroenterol. Hepatol. 6, 616\u2013620 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201369_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/bjs.6593","volume":"96","author":"CA Lamb","year":"2009","unstructured":"Lamb, C. A.  et al. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease. Br. J. Surg. 96, 663\u2013674 (2009).","journal-title":"Br. J. Surg."},{"key":"BFnrgastro201369_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s10620-011-2025-z","volume":"57","author":"D Sorrentino","year":"2012","unstructured":"Sorrentino, D.  et al. Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab-a pilot study. Dig. Dis. Sci. 57, 1341\u20131348 (2012).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro201369_CR12","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/gut.2005.081851","volume":"55","author":"A Bourreille","year":"2006","unstructured":"Bourreille, A.  et al. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: a prospective study. Gut 55, 978\u2013983 (2006).","journal-title":"Gut"},{"key":"BFnrgastro201369_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ibd.21003","volume":"16","author":"S Koilakou","year":"2010","unstructured":"Koilakou, S.  et al. Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection. Inflamm. Bowel Dis. 16, 198\u2013203 (2010).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1148\/radiol.09091165","volume":"254","author":"P Soyer","year":"2010","unstructured":"Soyer, P.  et al. Suspected anastomotic recurrence of Crohn disease after ileocolic resection: evaluation with CT enteroclysis. Radiology 254, 755\u2013764 (2010).","journal-title":"Radiology"},{"key":"BFnrgastro201369_CR15","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/ibd.20469","volume":"14","author":"F Castiglione","year":"2008","unstructured":"Castiglione, F.  et al. Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm. Bowel Dis. 14, 1240\u20131245 (2008).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/ibd.20872","volume":"15","author":"DB Sachar","year":"2009","unstructured":"Sachar, D. B.  et al. Recurrence patterns after first resection for stricturing or penetrating Crohn's disease. Inflamm. Bowel Dis. 15, 1071\u20131075 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ibd.21671","volume":"18","author":"T Watanabe","year":"2012","unstructured":"Watanabe, T.  et al. Interval of less than 5 years between the first and second operation is a risk factor for a third operation for Crohn's disease. Inflamm. Bowel Dis. 18, 17\u201324 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1365-2036.2012.05002.x","volume":"35","author":"A Buisson","year":"2012","unstructured":"Buisson, A., Chevaux, J. B., Allen, P. B., Bommelaer, G. & Peyrin-Biroulet, L. The natural history of post-operative Crohn's disease recurrence. Aliment. Pharmacol. Ther. 35, 625\u2013633 (2012).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201369_CR19","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1053\/j.gastro.2006.02.025","volume":"130","author":"M Ferrante","year":"2006","unstructured":"Ferrante, M.  et al. The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence. Gastroenterology 130, 1595\u20131606 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR20","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/ibd.20932","volume":"15","author":"SC Ng","year":"2009","unstructured":"Ng, S. C.  et al. Predictive value and clinical significance of myenteric plexitis in Crohn's disease. Inflamm. Bowel Dis. 15, 1499\u20131507 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR21","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1136\/gut.2009.177782","volume":"58","author":"H Sokol","year":"2009","unstructured":"Sokol, H.  et al. Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease. Gut 58, 1218\u20131225 (2009).","journal-title":"Gut"},{"key":"BFnrgastro201369_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/DCR.0b013e3181b7bfb0","volume":"53","author":"C Simillis","year":"2010","unstructured":"Simillis, C., Jacovides, M., Reese, G. E., Yamamoto, T. & Tekkis, P. P. Meta-analysis of the role of granulomas in the recurrence of Crohn disease. Dis. Colon Rectum 53, 177\u2013185 (2010).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro201369_CR23","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1046\/j.1365-2168.2000.01589.x","volume":"87","author":"O Bernell","year":"2000","unstructured":"Bernell, O., Lapidus, A. & Hellers, G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br. J. Surg. 87, 1697\u20131701 (2000).","journal-title":"Br. J. Surg."},{"key":"BFnrgastro201369_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1067\/msy.2001.109497","volume":"129","author":"T Yamamoto","year":"2001","unstructured":"Yamamoto, T., Allan, R. N. & Keighley, M. R. Long-term outcome of surgical management for diffuse jejunoileal Crohn's disease. Surgery 129, 96\u2013102 (2001).","journal-title":"Surgery"},{"key":"BFnrgastro201369_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s003840050065","volume":"11","author":"G Poggioli","year":"1996","unstructured":"Poggioli, G.  et al. Factors affecting recurrence in Crohn's disease. Results of a prospective audit. Int. J. Colorectal Dis. 11, 294\u2013298 (1996).","journal-title":"Int. J. Colorectal Dis."},{"key":"BFnrgastro201369_CR26","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/ibd.21825","volume":"18","author":"P De Cruz","year":"2012","unstructured":"De Cruz, P., Kamm, M. A., Prideaux, L., Allen, P. B. & Desmond, P. V. Postoperative recurrent luminal Crohn's disease: a systematic review. Inflamm. Bowel Dis. 18, 758\u2013777 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR27","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00384-008-0542-9","volume":"23","author":"GE Reese","year":"2008","unstructured":"Reese, G. E.  et al. The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. Int. J. Colorectal Dis. 23, 1213\u20131221 (2008).","journal-title":"Int. J. Colorectal Dis."},{"key":"BFnrgastro201369_CR28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1046\/j.1365-2168.2000.01443.x","volume":"87","author":"T Yamamoto","year":"2000","unstructured":"Yamamoto, T. & Keighley, M. R. Smoking and disease recurrence after operation for Crohn's disease. Br. J. Surg. 87, 398\u2013404 (2000).","journal-title":"Br. J. Surg."},{"key":"BFnrgastro201369_CR29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0016-5085(94)90697-1","volume":"106","author":"M Cottone","year":"1994","unstructured":"Cottone, M.  et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 106, 643\u2013648 (1994).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR30","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/S0016-5085(97)70001-5","volume":"113","author":"RS McLeod","year":"1997","unstructured":"McLeod, R. S.  et al. Risk and significance of endoscopic\/radiological evidence of recurrent Crohn's disease. Gastroenterology 113, 1823\u20131827 (1997).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR31","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00384-007-0329-4","volume":"22","author":"M Scarpa","year":"2007","unstructured":"Scarpa, M.  et al. Surgical predictors of recurrence of Crohn's disease after ileocolonic resection. Int. J. Colorectal Dis. 22, 1061\u20131069 (2007).","journal-title":"Int. J. Colorectal Dis."},{"key":"BFnrgastro201369_CR32","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1038\/ajg.2009.413","volume":"104","author":"G Maconi","year":"2009","unstructured":"Maconi, G.  et al. CARD15 gene variants and risk of reoperation in Crohn's disease patients. Am. J. Gastroenterol. 104, 2483\u20132491 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201369_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/BF02049478","volume":"39","author":"R Caprilli","year":"1996","unstructured":"Caprilli, R.  et al. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis. Colon Rectum 39, 335\u2013341 (1996).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro201369_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00000658-199603000-00005","volume":"223","author":"S Post","year":"1996","unstructured":"Post, S.  et al. The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease. Ann. Surg. 223, 253\u2013260 (1996).","journal-title":"Ann. Surg."},{"key":"BFnrgastro201369_CR35","doi-asserted-by":"publisher","first-page":"S1068","DOI":"10.1016\/S0016-5085(12)60711-2","volume":"142","author":"J Kinchen","year":"2012","unstructured":"Kinchen, J., Rajaratnam, K., Kingston, G., Mee, A. S. & De Silva, A. N. The presence of microscopic disease at the resection margins predicts post-surgical relapse in Crohn's Disease. Gastroenterology 142, S1068 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/00000658-199610000-00014","volume":"224","author":"VW Fazio","year":"1996","unstructured":"Fazio, V. W.  et al. Effects of resection margin on the recurrence of Crohn's disease in the small bowel: a randomized controlled trial. Ann. Surg. 224, 563\u2013571 (1996).","journal-title":"Ann. Surg."},{"key":"BFnrgastro201369_CR37","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1053\/j.gastro.2008.07.066","volume":"135","author":"S Renna","year":"2008","unstructured":"Renna, S.  et al. Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease. Gastroenterology 135, 1500\u20131509 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR38","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/0016-5085(95)90327-5","volume":"109","author":"RS McLeod","year":"1995","unstructured":"McLeod, R. S.  et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 109, 404\u2013413 (1995).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0016-5085(95)90059-4","volume":"108","author":"C Brignola","year":"1995","unstructured":"Brignola, C.  et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology 108, 345\u2013349 (1995).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR40","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/S0016-5085(97)70117-3","volume":"112","author":"LR Sutherland","year":"1997","unstructured":"Sutherland, L. R.  et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology 112, 1069\u20131077 (1997).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S0016-5085(00)70208-3","volume":"118","author":"H Lochs","year":"2000","unstructured":"Lochs, H.  et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology 118, 264\u2013273 (2000).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1046\/j.1365-2036.2003.01462.x","volume":"17","author":"R Caprilli","year":"2003","unstructured":"Caprilli, R.  et al. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: A pragmatic, double-blind, randomized controlled trial. Aliment. Pharmacol. Ther. 17, 517\u2013523 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201369_CR43","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1053\/gast.1997.v113.pm9352848","volume":"113","author":"C Camma","year":"1997","unstructured":"Camma, C., Giunta, M., Rosselli, M. & Cottone, M. Mesalamine in the maintenance treatment of Crohn's disease: A metaanalysis adjusted for confounding variables. Gastroenterology 113, 1465\u20131473 (1997).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR44","doi-asserted-by":"publisher","unstructured":"Doherty, G., Bennett, G., Patil, S., Cheifetz, A. & Moss, A. C. Interventions for prevention of post-operative recurrence of Crohn's disease. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD006873 \n                    http:\/\/dx.doi.org\/10.1002\/14651858.CD006873.pub2\n                    \n                   (2009).","DOI":"10.1002\/14651858.CD006873.pub2"},{"key":"BFnrgastro201369_CR45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ajg.2011.71","volume":"106","author":"AC Ford","year":"2011","unstructured":"Ford, A. C.  et al. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am. J. Gastroenterol. 106, 617\u2013629 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201369_CR46","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000199850","volume":"42","author":"K Ewe","year":"1989","unstructured":"Ewe, K., Herfarth, C., Malchow, H. & Jesdinsky, H. J. Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis: A multicenter trial. Digestion 42, 224\u2013232 (1989).","journal-title":"Digestion"},{"key":"BFnrgastro201369_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00042737-199903000-00011","volume":"11","author":"K Ewe","year":"1999","unstructured":"Ewe, K., Bottger, T., Buhr, H. J., Ecker, K.-W. & Otto, H. F. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur. J. Gastroenterol. Hepatol. 11, 277\u2013282 (1999).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201369_CR48","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0016-5085(99)70125-3","volume":"116","author":"G Hellers","year":"1999","unstructured":"Hellers, G.  et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 116, 294\u2013300 (1999).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR49","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/0016-5085(95)90121-3","volume":"108","author":"P Rutgeerts","year":"1995","unstructured":"Rutgeerts, P.  et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108, 1617\u20131621 (1995).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR50","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1053\/j.gastro.2005.01.010","volume":"128","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts, P.  et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 128, 856\u2013861 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR51","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.gastro.2004.06.051","volume":"127","author":"S Ardizzone","year":"2004","unstructured":"Ardizzone, S.  et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 127, 730\u2013740 (2004).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR52","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2004.07.037","volume":"127","author":"WJ Sandborn","year":"2004","unstructured":"Sandborn, W. J. & Feagan, B. G. The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain. Gastroenterology 127, 990\u2013993 (2004).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR53","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/ajg.2009.673","volume":"105","author":"P Papay","year":"2010","unstructured":"Papay, P.  et al. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery. Am. J. Gastroenterol. 105, 1158\u20131164 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201369_CR54","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1053\/j.gastro.2008.07.010","volume":"135","author":"G D'Haens","year":"2008","unstructured":"D'Haens, G.  et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's Disease: a controlled randomized trial. Gastroenterology 135, 1123\u20131129 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR55","first-page":"1525","volume":"55","author":"H Herfarth","year":"2006","unstructured":"Herfarth, H.  et al. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease. Gut 55, 1525\u20131526 (2006).","journal-title":"Gut"},{"key":"BFnrgastro201369_CR56","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1038\/ajg.2009.301","volume":"104","author":"L Peyrin-Biroulet","year":"2009","unstructured":"Peyrin-Biroulet, L.  et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am. J. Gastroenterol. 104, 2089\u20132096 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201369_CR57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/gut.49.1.42","volume":"49","author":"JF Colombel","year":"2001","unstructured":"Colombel, J. F.  et al. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut 49, 42\u201346 (2001).","journal-title":"Gut"},{"key":"BFnrgastro201369_CR58","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1080\/00365520510023729","volume":"40","author":"M Esaki","year":"2005","unstructured":"Esaki, M.  et al. Preventive effect of nutritional therapy against postoperative recurrence of Crohn disease, with reference to findings determined by intra-operative enteroscopy. Scand. J. Gastroenterol. 40, 1431\u20131437 (2005).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro201369_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2036.2006.03158.x","volume":"25","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto, T., Nakahigashi, M., Umegae, S., Kitagawa, T. & Matsumoto, K. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, non-randomized, parallel, controlled study. Aliment. Pharmacol. Ther. 25, 67\u201372 (2007).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201369_CR60","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00384-012-1587-3","volume":"28","author":"T Yamamoto","year":"2013","unstructured":"Yamamoto, T., Shiraki, M., Nakahigashi, M., Umegae, S. & Matsumoto, K. Enteral nutrition to suppress postoperative Crohn's disease recurrence: a five-year prospective cohort study. Int. J. Colorectal Dis. 28, 335\u2013340 (2013).","journal-title":"Int. J. Colorectal Dis."},{"key":"BFnrgastro201369_CR61","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/gut.51.3.405","volume":"51","author":"C Prantera","year":"2002","unstructured":"Prantera, C., Scribano, M. L., Falasco, G., Andreoli, A. & Luzi, C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: A randomised controlled trial with Lactobacillus GG. Gut 51, 405\u2013409 (2002).","journal-title":"Gut"},{"key":"BFnrgastro201369_CR62","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/gut.2005.076604","volume":"55","author":"P Marteau","year":"2006","unstructured":"Marteau, P.  et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: A randomised, double blind, placebo controlled GETAID trial. Gut 55, 842\u2013847 (2006).","journal-title":"Gut"},{"key":"BFnrgastro201369_CR63","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/ibd.20063","volume":"13","author":"A Van Gossum","year":"2007","unstructured":"Van Gossum, A.  et al. Multicenter randomized controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection. Inflamm. Bowel Dis. 13, 135\u2013142 (2007).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR64","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10620-006-9549-7","volume":"52","author":"I Chermesh","year":"2007","unstructured":"Chermesh, I.  et al. Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig. Dis. Sci. 52, 385\u2013389 (2007).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro201369_CR65","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/0140-6736(91)90663-A","volume":"338","author":"P Rutgeerts","year":"1991","unstructured":"Rutgeerts, P.  et al. Effect of fecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338, 771\u2013774 (1991).","journal-title":"Lancet"},{"key":"BFnrgastro201369_CR66","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","volume":"114","author":"G D'Haens","year":"1998","unstructured":"D'Haens, G.  et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114, 262\u2013267 (1998).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR67","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10350-004-0906-3","volume":"48","author":"A Fichera","year":"2005","unstructured":"Fichera, A., McCormack, R., Rubin, M. A., Hurst, R. D. & Michelassi, F. Long-term outcome of surgically treated Crohn's colitis: a prospective study. Dis. Colon Rectum 48, 963\u2013969 (2005).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro201369_CR68","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.dld.2011.02.017","volume":"43","author":"A Amiot","year":"2011","unstructured":"Amiot, A.  et al. Crohn's disease recurrence after total proctocolectomy with definitive ileostomy. Dig. Liver Dis. 43, 698\u2013702 (2011).","journal-title":"Dig. Liver Dis."},{"key":"BFnrgastro201369_CR69","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","volume":"362","author":"JF Colombel","year":"2010","unstructured":"Colombel, J. F.  et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N. Engl. J. Med. 362, 1383\u20131395 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201369_CR70","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(08)60304-9","volume":"371","author":"G D'Haens","year":"2008","unstructured":"D'Haens, G.  et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 371, 660\u2013667 (2008).","journal-title":"Lancet"},{"key":"BFnrgastro201369_CR71","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","volume":"359","author":"SB Hanauer","year":"2002","unstructured":"Hanauer, S. B.  et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359, 1541\u20131549 (2002).","journal-title":"Lancet"},{"key":"BFnrgastro201369_CR72","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1053\/j.gastro.2006.12.003","volume":"132","author":"J Hyams","year":"2007","unstructured":"Hyams, J.  et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 132, 863\u2013873 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR73","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1053\/j.gastro.2008.08.017","volume":"135","author":"L Peyrin-Biroulet","year":"2008","unstructured":"Peyrin-Biroulet, L., Bigard, M. A., Malesci, A. & Danese, S. Step-up and top-down approaches to the treatment of Crohn's disease: early may already be too late. Gastroenterology 135, 1420\u20131422 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR74","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","volume":"132","author":"JF Colombel","year":"2007","unstructured":"Colombel, J. F.  et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 132, 52\u201365 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR75","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/ajg.2010.78","volume":"105","author":"S Schreiber","year":"2010","unstructured":"Schreiber, S.  et al. Increased response and remission rates in short duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECISE 2 randomized maintenance trial data. Am. J. Gastroenterol. 105, 1574\u20131582 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201369_CR76","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00042737-200604000-00025","volume":"18","author":"D Sorrentino","year":"2006","unstructured":"Sorrentino, D.  et al. Prevention of postoperative recurrence of Crohn's disease by Infliximab. Eur. J. Gastroenterol. Hepatol. 18, 457\u2013459 (2006).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201369_CR77","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMoa020888","volume":"348","author":"F Baert","year":"2003","unstructured":"Baert, F.  et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N. Engl. J. Med. 348, 601\u2013608 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201369_CR78","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cgh.2010.01.016","volume":"8","author":"D Sorrentino","year":"2010","unstructured":"Sorrentino, D.  et al. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. Clin. Gastroenterol. Hepatol. 8, 591\u2013599 (2010).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201369_CR79","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/gut.2006.115980","volume":"56","author":"SB Hanauer","year":"2007","unstructured":"Hanauer, S. B. Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk? Gut 56, 1181\u20131183 (2007).","journal-title":"Gut"},{"key":"BFnrgastro201369_CR80","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1053\/j.gastro.2008.10.051","volume":"136","author":"M Regueiro","year":"2009","unstructured":"Regueiro, M.  et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 136, 441\u2013450 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR81","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/ibd.21925","volume":"18","author":"JE Baars","year":"2012","unstructured":"Baars, J. E., Nuij, V. J., Oldenburg, B., Kuipers, E. J. & van der Woude, C. J. Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation. Inflamm. Bowel Dis. 18, 1634\u20131640 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR82","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1002\/ibd.22999","volume":"19","author":"D Sorrentino","year":"2013","unstructured":"Sorrentino, D. Mucosal healing and clinical remission in inflammatory bowel diseases: Are we missing something here? Inflamm. Bowel Dis. 19, E55\u2013E56 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR83","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/ibd.21928","volume":"18","author":"K Yoshida","year":"2012","unstructured":"Yoshida, K.  et al. Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial. Inflamm. Bowel Dis. 18, 1617\u20131623 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR84","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00384-011-1398-y","volume":"27","author":"A Sakuraba","year":"2012","unstructured":"Sakuraba, A.  et al. The use of infliximab in the prevention of postsurgical recurrence in polysurgery Crohn's disease patients: a pilot, open-labeled prospective study. Int. J. Colorectal Dis. 27, 947\u2013952 (2012).","journal-title":"Int. J. Colorectal Dis."},{"key":"BFnrgastro201369_CR85","doi-asserted-by":"publisher","first-page":"S-592","DOI":"10.1016\/S0016-5085(11)62450-5","volume":"140","author":"S Tarekegn","year":"2011","unstructured":"Tarekegn, S.  et al. Biologics are superior to immunomodulators in prevention of post-operative recurrence of Crohn's disease. Gastroenterology 140, S-592 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR86","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.crohns.2012.02.012","volume":"6","author":"K Papamichael","year":"2012","unstructured":"Papamichael, K., Archavlis, E., Lariou, C. & Mantzaris, G. J. Adalimumab for the prevention and\/or treatment of post-operative recurrence of Crohn's disease: A prospective, two-year, single center, pilot study. J. Crohns Colitis 6, 924\u2013931 (2012).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro201369_CR87","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MEG.0b013e328353a32a","volume":"24","author":"E Savarino","year":"2012","unstructured":"Savarino, E., Dulbecco, P., Bodini, G., Assandri, L. & Savarino, V. Prevention of postoperative recurrence of Crohn's disease by Adalimumab: a case series. Eur. J. Gastroenterol. Hepatol. 24, 468\u2013470 (2012).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201369_CR88","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.3748\/wjg.v18.i32.4391","volume":"18","author":"M Aguas","year":"2012","unstructured":"Aguas, M.  et al. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. World J. Gastroenterol. 18, 4391\u20134398 (2012).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro201369_CR89","first-page":"S692","volume":"138","author":"I Fernandez-Blanco","year":"2010","unstructured":"Fernandez-Blanco, I., Monturiol, J. & Martinez, B. Adalimumab in the prevention of postoperative recurrence of Crohn's disease. Gastroenterology 138, S692 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR90","doi-asserted-by":"publisher","first-page":"S212","DOI":"10.1016\/S0016-5085(12)60794-X","volume":"142","author":"P De Cruz","year":"2012","unstructured":"De Cruz, P.  et al. Adalimumab prevents post-operative Crohn's disease recurrence, and is superior to thiopurines: early results from the POCER Study. Gastroenterology 142, S212 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR91","first-page":"1","volume":"490","author":"G Hellers","year":"1979","unstructured":"Hellers, G. Crohn's disease in Stockholm county 1955\u20131974 A study of epidemiology, results of surgical treatment and long-term prognosis. Acta Chir. Scand. Suppl. 490, 1\u201384 (1979).","journal-title":"Acta Chir. Scand. Suppl."},{"key":"BFnrgastro201369_CR92","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.gie.2005.08.047","volume":"63","author":"L Biancone","year":"2006","unstructured":"Biancone, L.  et al. Local injection of Infliximab in the postoperative recurrence of Crohn's disease. Gastrointest. Endosc. 63, 486\u2013492 (2006).","journal-title":"Gastrointest. Endosc."},{"key":"BFnrgastro201369_CR93","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/ibd.20915","volume":"15","author":"T Yamamoto","year":"2009","unstructured":"Yamamoto, T., Umegae, S. & Matsumoto, K. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study. Inflamm. Bowel Dis. 15, 1460\u20131466 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR94","first-page":"S-660","volume":"142","author":"E Boueyre","year":"2012","unstructured":"Boueyre, E.  et al. Efficacy of anti-TNF on severe postoperative endoscopic recurrence in Crohn's disease. Gastroenterology 142, S-660 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR95","doi-asserted-by":"publisher","first-page":"S694","DOI":"10.1053\/j.gastro.2009.09.058","volume":"138","author":"M Regueiro","year":"2010","unstructured":"Regueiro, M.  et al. 4.5 Yr follow-up of patients enrolled in the randomized controlled trial (RCT) of infliximab (Inf) for prevention of postoperative Crohn's disease (CD). Gastroenterology 138, S694 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR96","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/ajg.2008.88","volume":"104","author":"JP Gisbert","year":"2009","unstructured":"Gisbert, J. P. & Pan\u00e9s, J. Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review. Am. J. Gastroenterol. 104, 760\u2013767 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201369_CR97","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1016\/S1590-8658(08)60530-7","volume":"40","author":"S Danese","year":"2008","unstructured":"Danese, S. Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker. Dig. Liver Dis. 40, S225\u2013S228 (2008).","journal-title":"Dig. Liver Dis."},{"key":"BFnrgastro201369_CR98","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2009.08.011","volume":"31","author":"MJ Barnes","year":"2009","unstructured":"Barnes, M. J. & Powrie, F. Regulatory T cells reinforce intestinal homeostasis. Immunity 31, 401\u2013411 (2009).","journal-title":"Immunity"},{"key":"BFnrgastro201369_CR99","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec, P., Korn, T. & Kuchroo, V. K. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 361, 888\u2013898 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201369_CR100","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cgh.2010.04.014","volume":"8","author":"CN Bernstein","year":"2010","unstructured":"Bernstein, C. N. Anti-tumor necrosis factor therapy in Crohn's disease: more information and more questions about the long term. Clin. Gastroenterol. Hepatol. 8, 556\u2013558 (2010).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201369_CR101","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1053\/j.gastro.2011.09.034","volume":"142","author":"E Louis","year":"2012","unstructured":"Louis, E.  et al. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology 142, 63\u201370 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR102","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/j.1365-2036.2010.04446.x","volume":"32","author":"AW Waugh","year":"2010","unstructured":"Waugh, A. W.  et al. Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort. Aliment. Pharmacol. Ther. 32, 1129\u20131134 (2010).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201369_CR103","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/gut.2008.155812","volume":"58","author":"F Schnitzler","year":"2009","unstructured":"Schnitzler, F.  et al. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Gut 58, 492\u2013500 (2009).","journal-title":"Gut"},{"key":"BFnrgastro201369_CR104","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/j.gastro.2009.09.056","volume":"138","author":"F Baert","year":"2010","unstructured":"Baert, F.  et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 138, 463\u2013468 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR105","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3109\/00365521.2012.660541","volume":"47","author":"C Steenholdt","year":"2012","unstructured":"Steenholdt, C.  et al. Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study. Scand. J. Gastroenterol. 47, 518\u2013527 (2012).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro201369_CR106","unstructured":"Sorrentino, D.  et al. Low dose infliximab for prevention of postoperative recurrence of Crohn's disease: long term follow-up and impact of infliximab trough levels and antibodies to infliximab. Gastroenterology (in press)."},{"key":"BFnrgastro201369_CR107","first-page":"S1159","volume":"142","author":"N Van de Casteele","year":"2012","unstructured":"Van de Casteele, N.  et al. Results on the optimisation phase of the prospective controlled trough level adapted infliximab treatment (TAXIT) trial. Gastroenterology 142, S1159 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR108","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/00365521.2010.536254","volume":"46","author":"C Steenholdt","year":"2011","unstructured":"Steenholdt, C.  et al. Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease. Scand. J. Gastroenterol. 46, 310\u2013318 (2011).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro201369_CR109","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/ibd.20899","volume":"15","author":"A Cassinotti","year":"2009","unstructured":"Cassinotti, A. & Travis, S. Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic review. Inflamm. Bowel Dis. 15, 1264\u20131275 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201369_CR110","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz, T.  et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. JAMA 295, 2275\u20132278 (2006).","journal-title":"JAMA"},{"key":"BFnrgastro201369_CR111","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.dld.2011.12.018","volume":"44","author":"A Buisson","year":"2012","unstructured":"Buisson, A., Chevaux, J. B., Bommelaer, G. & Peyrin-Biroulet, L. Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence. Dig. Liver Dis. 44, 453\u2013460 (2012).","journal-title":"Dig. Liver Dis."},{"key":"BFnrgastro201369_CR112","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11894-010-0152-x","volume":"13","author":"M Schwartz","year":"2011","unstructured":"Schwartz, M. & Regueiro, M. Prevention and treatment of postoperative Crohn's disease recurrence: an update for a new decade. Curr. Gastroenterol. Rep. 13, 95\u2013100 (2011).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"BFnrgastro201369_CR113","first-page":"3213","volume":"17","author":"A Spinelli","year":"2011","unstructured":"Spinelli, A., Sacchi, M., Fiorino, G., Danese, S. & Montorsi, M. Risk of postoperative recurrence and postoperative management of Crohn's disease. World J. Gastroenterol. 17, 3213\u20133219 (2011).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro201369_CR114","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","volume":"4","author":"G Van Assche","year":"2010","unstructured":"Van Assche, G.  et al. European Crohn's and Colitis Organisation (ECCO). The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J. Crohns Colitis 4, 63\u2013101 (2010).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro201369_CR115","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2036.2011.04577.x","volume":"33","author":"L Peyrin-Biroulet","year":"2011","unstructured":"Peyrin-Biroulet, L., Oussalah, A., Roblin, X. & Sparrow, M. P. The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts. Aliment. Pharmacol. Ther. 33, 707\u2013713 (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201369_CR116","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.3748\/wjg.v16.i43.5405","volume":"16","author":"T Yamamoto","year":"2010","unstructured":"Yamamoto, T. Prevention of recurrence after surgery for Crohn's disease: efficacy of infliximab. World J. Gastroenterol. 16, 5405\u20135410 (2010).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro201369_CR117","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1155\/2011\/591347","volume":"25","author":"AM Borowiec","year":"2011","unstructured":"Borowiec, A. M. & Fedorak, R. N. Predicting, treating and preventing postoperative recurrence of Crohn's disease: the state of the field. Can. J. Gastroenterol. 25, 140\u2013146 (2011).","journal-title":"Can. J. Gastroenterol."},{"key":"BFnrgastro201369_CR118","doi-asserted-by":"publisher","first-page":"S568","DOI":"10.1016\/S0016-5085(12)62180-5","volume":"142","author":"P De Cruz","year":"2012","unstructured":"De Cruz, P.  et al. Clinical risk stratification predicts development of endoscopic recurrence after Crohn's disease surgery: early results from the POCER Study. Gastroenterology 142, S568 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201369_CR119","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/gut.2004.049460","volume":"54","author":"A Kandiel","year":"2005","unstructured":"Kandiel, A.  et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 54, 1121\u20131125 (2005).","journal-title":"Gut"},{"key":"BFnrgastro201369_CR120","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/gut.2009.194159","volume":"59","author":"W Reinisch","year":"2010","unstructured":"Reinisch, W.  et al. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut 59, 752\u2013759 (2010).","journal-title":"Gut"},{"key":"BFnrgastro201369_CR121","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1007\/s10350-007-0279-5","volume":"50","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto, T., Fazio, V. W. & Tekkis, P. P. Safety and efficacy of strictureplasty for Crohn's disease: a systematic review and meta-analysis. Dis. Colon Rectum 50, 1968\u20131986 (2007).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro201369_CR122","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrgastro201369_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2036.2011.04679.x","volume":"34","author":"S Danese","year":"2011","unstructured":"Danese, S., Fiorino, G. & Reinisch, W. Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-\u03b1 therapy. Aliment. Pharmacol. Ther. 34, 1\u201310 (2011).","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.69.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.69","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.69.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:49:44Z","timestamp":1684468184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,7]]},"references-count":123,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFnrgastro201369"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2013.69","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,7]]}}}